Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2880 (118th)

Protecting Patients Against PBM Abuses Act

referredUnited States· United States Congress· EN

Introduced

26 April 2023

Last action

17 December 2024 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Carter, Earl L. "Buddy" [R-GA-1], Sen. Blunt Rochester, Lisa [D-DE], Rep. Malliotakis, Nicole [R-NY-11], Rep. Auchincloss, Jake [D-MA-4], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Miller-Meeks, Mariannette [R-IA-1], Rep. Ross, Deborah K. [D-NC-2], Rep. Dunn, Neal P. [R-FL-2], Jerry Carl, Rep. Mann, Tracey [R-KS-1], Rep. Ferguson, A. Drew, IV [R-GA-3], Rep. Harshbarger, Diana [R-TN-1], Rep. Allen, Rick W. [R-GA-12], Rep. Miller, Carol D. [R-WV-1], Rep. Valadao, David G. [R-CA-22], Rep. Cleaver, Emanuel [D-MO-5], Rep. Sherrill, Mikie [D-NJ-11], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Scott, Austin [R-GA-8], Rep. Cherfilus-McCormick, Sheila [D-FL-20], Rep. Davis, Donald G. [D-NC-1], Rep. Hudson, Richard [R-NC-8], Rep. Fleischmann, Charles J. "Chuck" [R-TN-3], Rep. Cartwright, Matt [D-PA-17], Rep. Jackson, Jonathan L. [D-IL-1], Rep. Vasquez, Gabe [D-NM-2], Rep. Spanberger, Abigail Davis [D-VA-7], Rep. Salinas, Andrea [D-OR-6], Rep. McCormick, Richard [R-GA-7], Rep. Lawler, Michael [R-NY-17], Rep. Grothman, Glenn [R-WI-6], Rep. Rose, John W. [R-TN-6], Yadira Caraveo, Rep. Flood, Mike [R-NE-1], Rep. Levin, Mike [D-CA-49], Rep. LaLota, Nick [R-NY-1], Rep. Kiggans, Jennifer A. [R-VA-2], Rep. James, John [R-MI-10], Rep. Krishnamoorthi, Raja [D-IL-8], Rep. Van Orden, Derrick [R-WI-3], Rep. Smucker, Lloyd [R-PA-11], Mike Garcia, Rep. Tenney, Claudia [R-NY-24], Rep. Morelle, Joseph D. [D-NY-25], Rep. Nickel, Wiley [D-NC-13], Rep. Menendez, Robert [D-NJ-8]

Subjects

Healthcare

Source updated

27 May 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Protecting Patients Against PBM Abuses Act This bill establishes requirements for Medicare pharmacy benefit managers (PBMs) with respect to remuneration, payments, and fees. Specifically, the bill restricts PBMs that are under contract with plans under the Medicare prescription drug benefit or Medicare Advantage from (1) receiving income for their services other than flat dollar amount service fees; (2) basing any service fees on the prices of covered drugs or any associated discounts, rebates, or other remuneration; (3) charging plan sponsors for ingredient costs or dispensing fees in amounts that are different than what is reimbursed to the pharmacy; or (4) reimbursing network pharmacies for less than that what is reimbursed to PBM-affiliated pharmacies. Such PBMs must also report on the difference between certain costs for drugs on the plan's formulary and those that are not on the formulary but are therapeutically equivalent. PBMs must also report certain information regarding rebates and fees they receive from drug manufacturers; the Centers for Medicare & Medicaid Services must publish this and other information that is currently reported by PBMs online.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 26 April 2023

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 26 April 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 26 April 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 28 April 2023

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 15 November 2023

    Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote.

    Source: Committee

  6. 15 November 2023

    Committee

    Subcommittee Consideration and Mark-up Session Held

    Source: Committee

  7. 5 December 2023

    Committee

    Committee Consideration and Mark-up Session Held

    Source: Committee

  8. 6 December 2023

    Vote

    Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.

    Source: Committee

  9. 6 December 2023

    Committee

    Committee Consideration and Mark-up Session Held

    Source: Committee

  10. 17 December 2024

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 26 April 2023

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 26 April 2023

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 26 April 2023

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.